New study seeks to predict which cervical precancers will disappear without surgery
NCT ID NCT06147388
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 300 women aged 18–40 with severe cervical precancer (CIN 2 or 3) to see how often these lesions regress on their own or after surgery. Researchers will track HPV and Pap test results to identify factors that predict healing. The goal is to create a model that helps doctors decide who can safely avoid surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General University Hospital
RECRUITINGPrague, 12800, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could Self-Sampling revolutionize cervical cancer screening?
- Texting parents could be key to curbing HPV-Related cancers
- Pocket-sized HIV test could bring same-day diagnosis to community clinics
- Could a blast of argon plasma wipe out cervical precancer without surgery?
- Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
- HPV DNA test could slash cervical cancer deaths in High-Risk populations